Variant report
Variant | nsv974347 |
---|---|
Chromosome Location | chr14:65062237-65068257 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:245)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr14:65065124-65065386 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr14:65065161-65065359 | GM12878 | blood: | n/a | n/a |
3 | BHLHE40 | chr14:65065076-65065511 | GM12878 | blood: | n/a | n/a |
4 | CTCF | chr14:65063040-65063190 | HRPEpiC | eye: | n/a | n/a |
5 | CTCF | chr14:65068030-65068068 | GM10248 | blood: | n/a | n/a |
6 | EP300 | chr14:65065223-65065361 | GM12878 | blood: | n/a | n/a |
7 | FOS | chr14:65063293-65063369 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | SPI1 | chr14:65065239-65065419 | GM12878 | blood: | n/a | n/a |
9 | SPI1 | chr14:65065211-65065478 | GM12878 | blood: | n/a | n/a |
10 | SPI1 | chr14:65065195-65065518 | GM12891 | blood: | n/a | n/a |
11 | SPI1 | chr14:65064919-65065590 | GM12878 | blood: | n/a | n/a |
12 | SPI1 | chr14:65065127-65065477 | GM12891 | blood: | n/a | n/a |
13 | STAT3 | chr14:65065280-65065443 | GM12878 | blood: | n/a | chr14:65065334-65065342 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:65066517-65066567 | AG09309 | skin: | n/a |
2 | chr14:65066517-65066567 | AG09309 | skin: | n/a |
3 | chr14:65066517-65066567 | ProgFib | skin: | n/a |
4 | chr14:65066517-65066567 | AoSMC | blood vessel: | n/a |
5 | chr14:65066517-65066567 | MCF-7 | breast: | n/a |
6 | chr14:65066517-65066567 | ECC-1 | luminal epithelium: | n/a |
7 | chr14:65066517-65066567 | HCPEpiC | choroid plexus: | n/a |
8 | chr14:65066517-65066567 | U87 | brain: | n/a |
9 | chr14:65066517-65066567 | SK-N-SH | brain: | n/a |
10 | chr14:65067858-65067908 | HAEpiC | amniotic membrane: | n/a |
11 | chr14:65067858-65067908 | HepG2 | liver: | n/a |
12 | chr14:65065830-65065880 | GM19239 | blood: | n/a |
13 | chr14:65066622-65066672 | HAEpiC | amniotic membrane: | n/a |
14 | chr14:65067858-65067908 | U87 | brain: | n/a |
15 | chr14:65066517-65066567 | HEEpiC | esophagus: | n/a |
16 | chr14:65067858-65067908 | SK-N-SH | brain: | n/a |
17 | chr14:65067858-65067908 | AG04449 | skin: | fetal |
18 | chr14:65066517-65066567 | BE2_C | brain: | n/a |
19 | chr14:65066622-65066672 | NB4 | blood: | n/a |
20 | chr14:65067858-65067908 | SK-N-MC | brain: | n/a |
21 | chr14:65067858-65067908 | SKMC | muscle: | n/a |
22 | chr14:65066622-65066672 | GM12878 | blood: | n/a |
23 | chr14:65066622-65066672 | RPTEC | kidney: | n/a |
24 | chr14:65067858-65067908 | IMR90 | lung: | fetal |
25 | chr14:65066517-65066567 | HNPCEpiC | eye: | n/a |
26 | chr14:65066517-65066567 | AG10803 | skin: | n/a |
27 | chr14:65067858-65067908 | AG09309 | skin: | n/a |
28 | chr14:65066622-65066672 | PrEC | prostate: | n/a |
29 | chr14:65066622-65066672 | Caco-2 | colon: | n/a |
30 | chr14:65066622-65066672 | HRPEpiC | eye: | n/a |
31 | chr14:65066517-65066567 | HRCEpiC | kidney: | n/a |
32 | chr14:65065830-65065880 | NT2-D1 | testis: | n/a |
33 | chr14:65066517-65066567 | MCF10A-Er-Src | breast: | n/a |
34 | chr14:65066517-65066567 | HCF | heart: | n/a |
35 | chr14:65065830-65065880 | SK-N-MC | brain: | n/a |
36 | chr14:65066622-65066672 | HCM | heart: | n/a |
37 | chr14:65066622-65066672 | GM19239 | blood: | n/a |
38 | chr14:65065830-65065880 | GM12878 | blood: | n/a |
39 | chr14:65065830-65065880 | U87 | brain: | n/a |
40 | chr14:65067858-65067908 | GM12878 | blood: | n/a |
41 | chr14:65066517-65066567 | HRPEpiC | eye: | n/a |
42 | chr14:65065830-65065880 | GM12891 | blood: | n/a |
43 | chr14:65065830-65065880 | HUVEC | blood vessel: | n/a |
44 | chr14:65065830-65065880 | H1-hESC | embryonic stem cell: | embryo |
45 | chr14:65067858-65067908 | ovcar-3 | ovarian: | n/a |
46 | chr14:65067858-65067908 | HEEpiC | esophagus: | n/a |
47 | chr14:65065830-65065880 | MCF10A-Er-Src | breast: | n/a |
48 | chr14:65067858-65067908 | RPTEC | kidney: | n/a |
49 | chr14:65067858-65067908 | HCPEpiC | choroid plexus: | n/a |
50 | chr14:65066517-65066567 | T-47D | breast: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:65006378..65008389-chr14:65060935..65063118,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZBTB25-4 | chr14:65063180-65063254 | ENSG00000259076.1 |
2 | lnc-ZBTB25-4 | chr14:65063180-65063231 | ENSG00000259076.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000259076 | TF binding region |
ENSG00000259076 | CpG island |
ENSG00000259116 | chromatin interactions |
ENSG00000126803 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78977997 | chr14:65062263-65062264 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs533987311 | chr14:65062300-65062301 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs137903028 | chr14:65062355-65062356 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs573663164 | chr14:65062356-65062357 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs542645707 | chr14:65062585-65062586 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs148116867 | chr14:65062586-65062587 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs556416692 | chr14:65062592-65062593 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs570487800 | chr14:65062620-65062621 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs190017554 | chr14:65062624-65062625 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs142368436 | chr14:65062644-65062645 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs572604437 | chr14:65062684-65062685 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs540743501 | chr14:65062708-65062709 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs560981592 | chr14:65062719-65062720 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs181092041 | chr14:65062722-65062723 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs146385650 | chr14:65062776-65062777 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs563575125 | chr14:65062824-65062825 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs185781860 | chr14:65062836-65062837 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs552446413 | chr14:65062881-65062882 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs188147762 | chr14:65062887-65062888 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs549170970 | chr14:65062905-65062906 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs534831331 | chr14:65062948-65062949 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs201483772 | chr14:65063030-65063031 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs139412330 | chr14:65063040-65063041 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs150025631 | chr14:65063041-65063042 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs536241553 | chr14:65063046-65063047 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs144362013 | chr14:65063049-65063050 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs576038405 | chr14:65063053-65063054 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs561179222 | chr14:65063220-65063221 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs73269771 | chr14:65063221-65063222 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs367946669 | chr14:65063251-65063252 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs180994608 | chr14:65063262-65063263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541646387 | chr14:65063265-65063266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10134770 | chr14:65063315-65063316 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs558172182 | chr14:65063318-65063319 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs574634484 | chr14:65063322-65063323 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs543434811 | chr14:65063323-65063324 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs186370100 | chr14:65063450-65063451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532152758 | chr14:65063507-65063508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552151025 | chr14:65063531-65063532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559631026 | chr14:65063535-65063536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74056334 | chr14:65063590-65063591 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs142818199 | chr14:65063606-65063607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548027790 | chr14:65063659-65063660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs17113852 | chr14:65063699-65063700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546799483 | chr14:65063725-65063726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567412710 | chr14:65063811-65063812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559974656 | chr14:65063826-65063827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536305712 | chr14:65063835-65063836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9630388 | chr14:65063922-65063923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549866224 | chr14:65063925-65063926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 22032731 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17603634 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Autism | 22543975 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Hematopoietic stem cell | 20738155 | CNVD |
Cancer | 17440070 | CNVD |
Intracranial arachnoid cysts | 20187927 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:65048800-65068400 | Weak transcription | Pancreas | Pancrea |
2 | chr14:65058800-65062800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr14:65061200-65062400 | Enhancers | HepG2 | liver |
4 | chr14:65062800-65063200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr14:65065000-65065800 | Enhancers | GM12878-XiMat | blood |
6 | chr14:65065000-65066200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr14:65065200-65065800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr14:65065800-65068400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr14:65068200-65068400 | Active TSS | Skeletal Muscle Female | skeletal muscle |
10 | chr14:65068200-65068600 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr14:65068200-65068600 | Active TSS | Duodenum Smooth Muscle | Duodenum |